Global Health Challenges

Eighteen challenges.
One analytical platform.

Open-access analytics, evidence and practical frameworks for global health challenges.

The challenge spectrum

18 active programmes
Global Health Challenges
Choose a challenge
Each segment opens a full challenge ecosystem.

Hover or tap a segment to preview it, then select it to open the challenge.

18Challenges
5Consortium members
Openaccess
Globalscope

About the consortium

Evidence, analytics and delivery for global health

The Global Health Challenges (GHC) platform collects open-access analytics and assets curated by the GHC Consortium, a collaborative project between several strategically aligned groups including Oxy Wave Foundation, Biogerontology Research Foundation, Philanthropy.International, Longevity.Group and Longevity Industry Analytics. The GHC program combines deep analytics, curated evidence and program-level blueprints to tackle complex, high-impact global health challenges at scale.

The consortium’s assets and activities span systematic first-of-its-kind data aggregation and canonical databases, decision-grade analytical reports and special dossiers, pilotable clinical and community interventions, and partnership frameworks that move proofs-of-concept into population-level policy and practice. We focus equally on scientific rigour and operational practicality. Each challenge—Lyme, Autism, neurodegenerative diseases, Diabetes, antimicrobial threats, toxic exposures, infertility, children’s health, PTSD and structural causes of “future shock”—is addressed by a tailored mix of analytics, targeted pilot programs, technical whitepapers and confidential policy briefs.

Our platform surfaces prioritized opportunities for funders, governments, health systems and commercial partners, and our pilots (e.g., community recruitment, clinical pathway rollouts and digital engagement experiments) are designed to be measurable, reproducible and scalable. If you are a researcher, funder, clinician or civic stakeholder interested in partnering, sponsoring or accessing GHC reports, request our short public briefings or apply for gated access to full technical dossiers. By aligning data, domain expertise, and operational capacity, we aim to accelerate evidence-based progress where it matters most.

Intelligence infrastructure

See the ecosystem, not just the symptom

GHC analytical assets turn raw information into structured market, scientific, institutional and implementation intelligence, with visual tools built for practical decisions.

Big Data Analytics Dashboard

Interactive analytical tools for structured, data-driven decision support across health ecosystems.

InteractiveAnalyticalDecision support
Open dashboard

GHC Ecosystem Mind Map

Navigate organisations, technologies and relationships across the global health challenge landscape.

Network viewEcosystem mappingCross-sector
Open the map

Global Clinics Industry Dashboard

Structured intelligence on providers, clinics and delivery-side infrastructure within the care ecosystem.

Provider intelligenceInfrastructureClinic landscape
Open dashboard

What decision-makers can extract

The point is not visual complexity. It is seeing dependencies, gaps, credible partners and high-leverage next steps before capital or operational resources are committed.

Gap analysisWhat is missing across evidence, providers, funding and implementation pathways.
Partner discoveryWhich organisations, technologies and institutions are positioned to collaborate.
Pilot prioritisationFrom ecosystem map to specific intervention hypotheses and rollout options.

GHC analytical framework

A common language for complex health systems

Health outcomes emerge from interacting systems, not isolated variables. The framework links each challenge to the technology sectors, providers, institutions, policies and economics that shape real-world results.

  1. 1

    Discover Evidence and data

    Gather and assess the available evidence, assets and open questions.

  2. 2

    Map Technology sectors

    Structure the relevant technology sectors and operating environment.

  3. 3

    Connect Providers and capital

    Link providers, partners, funders and implementation stakeholders.

  4. 4

    Govern Policy and institutions

    Overlay policy, institutional and regulatory realities.

  5. 5

    Test Pilots and interventions

    Design pilots, interventions and practical next-step hypotheses.

  6. 6

    Scale Population impact

    Move validated approaches toward sustained population-level impact.

Technology sectors

Diagnostics, therapeutics, prevention, rehabilitation and enabling infrastructure.

Providers and stakeholders

Clinics, companies, NGOs, social enterprises, investors and institutions.

Policy and government

Regulation, public initiatives, reimbursement and implementation pathways.

Economic context

Capital, trade, incentives, market structures and access constraints.

Research and education

Scientific capability, knowledge transfer and evidence maturity.

Population outcomes

Prevention, resilience, access, quality, equity and measurable impact.

From evidence to action

Four asset classes

Data aggregation

Find-and-share canonical databases across each challenge domain.

Analytical reports

Decision-grade reports and special dossiers for funders and policymakers.

Pilotable interventions

Clinical and community programmes designed to be measurable and reproducible.

Partnership frameworks

Structures that move proof-of-concept into population-level policy and practice.

Get involved

Help shape the next breakthrough

Researchers, funders, clinicians and civic stakeholders each have a defined way to participate.

Researchers

Collaborate on analytics, contribute data, co-author reports.

Funders

Direct capital to prioritised, measurable interventions.

Clinicians

Run pilots, apply protocols, contribute outcome data.

Civic and policy

Translate evidence into policy and population-scale practice.

Support a challenge.
Help advance the work.

Contributions are directed to a named challenge and reported against measurable outcomes.